The evolution of anti-emetic prescriptions in primary care, between 2006 and 2016.
David De BandtSarah SafsafBastien BourrionMathilde FrançoisPublished in: Pharmacoepidemiology and drug safety (2020)
Decreases in anti-emetic prescription rates and public health expenditures preceded the publication of official recommendations to reduce the use of metoclopramide and domperidone, without prescription transfers for metopimazine.